For more than a century since its founding in 1915, the Denka Group has consistently created new value through its unique technologies and products while remaining strongly committed to addressing the social challenges of each era.

The world today is facing an era of unprecedented uncertainty, marked by rising geopolitical risks, supply chain instability, volatility in energy and resource prices, the emergence of infectious disease risks, and structural changes in industries driven by the rapid advancement of AI. While such changes are making a significant impact on corporate activities, they also present major opportunities for creating new industries and resolving social challenges.

In light of these changes in the business environment, and to clarify once again the significance of the Denka Group’s existence and chart a course for medium- to long-term growth, we adopted our purpose: "Make the world a better place as specialists in chemistry”, in fiscal year 2023 and have been advancing initiatives to achieve it.

At the same time, with the aim of continuously enhancing corporate value, we have formulated Mission 2030, a management plan covering fiscal years 2023 to 2030, centered on three growth strategies: “Business Value Creation”, “Human Resources Value Creation”, and “Management Value Creation”. We have been developing our business with an emphasis on three focus areas: ICT & Energy, Healthcare, and Sustainable Living.

Three years have passed since the formulation of Mission 2030, and the market environment and supply-demand dynamics for the EV and semiconductor sectors have changed significantly, resulting in some discrepancies from our initial assumptions. Given these circumstances, during my first year as president, I have focused on developing and implementing various initiatives aimed at returning the Denka Group to a growth track and driving further growth.
As part of these efforts, we revised our management plan in February of this year and designated the fiscal years 2026 to 2028 as Mission 2030 Phase 2, positioning this period with the goals of “rebuilding earning power” and “strengthening foundations for a new growth stage”. With a focus on the ICT & Energy and Healthcare sectors, we aim to achieve record-high profits and an ROE of 8% or higher during this phase by improving our profitability and enhancing our business competitiveness. Furthermore, in the Phase 3 that follows, we will leverage the foundation of earning power we rebuilt in Phase 2, to further refine “the best mix of ICT & Energy and Healthcare”, which have different growth trends to ensure the successful commercialization of new business themes and accelerate the creation of sustainable value unique to Denka.

To achieve our plan, we will not only improve productivity and implement cost reforms company-wide by rolling out best practices, but we will also further strengthen our non-financial strategies, including environmental management, DE&I, and risk management. Furthermore, to ensure these initiatives lead to tangible results, we will continue to engage in dialogue with our stakeholders as we work to steadily execute Mission 2030.

The Denka Group will continue to contribute to people’s daily lives and the advancement of society, combining its world-renowned strength in chemistry with its core values of “Initiative”, “Integrity”, and “Empathy”. In doing so, the Group will also continue to meet the expectations and live up to the trust of its stakeholders. Furthermore, under my motto of “Initiative and Execution”, we will drive transformation and deliver on our commitments. We appreciate your continued understanding and support.